Drug-Exposome Interactions: The Next Frontier in Precision Medicine.

Manuel Pristner, Benedikt Warth

Journal: Trends in pharmacological sciences 2021;41(12):994-1005

PMID: 33186555

Abstract

Drug-drug interactions are a known concern during medical treatment. However, in addition to therapeutic drugs, humans are exposed to thousands of environment- and food-related chemicals on a daily basis. The exposome (i.e.,the total measure of environmental factors on the human body) is an emerging concept in the field of environmental health. Many chemicals have the potential to interact with drugs and subsequently influence health outcomes. To date, this concept has not been systematicallyinvestigated. Nevertheless, adverse effects have been observed betweenenvironmental, dietary, and microbiome-derived xenobiotics and a number of drugs, including chemotherapeutics. Recent technological advances in mass spectrometry-based metabolomics and the establishment of omic-scale exposure assessment will enable a broader and systemic investigation of these interactions. As a complement to pharmacogenomics and pharmacometabolomics, research ondrug-exposome interactions holds immense potential to elevate precision medicineto an unprecedented level.

Copyright © 2020 Elsevier Ltd. All rights reserved.

Address: University of Vienna, Faculty of Chemistry, Department of Food Chemistry and Toxicology, Vienna, Austria.; University of Vienna, Faculty of Chemistry, Department of Food Chemistry and Toxicology, Vienna, Austria. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.